Design and evaluation of ocular hydrogel containing combination of ofloxacin and dexamethasone for the treatment of conjunctivitis
DOI:
https://doi.org/10.1590/s2175-97902022e20180Keywords:
Conjunctivitis, Cross link, Hydrogel, Ocular, pH sensitiveAbstract
Conjunctivitis is an inflammation of the conjunctiva, which covers the white part of the eyeball. It can be caused by allergies, bacterial or viral infection. In situ hydrogels are three-dimensional hydrophilic cross-linked network of polymers. In situ hydrogel provided better therapeutic index when compared to conventional treatment. The present work describes the formulation and evaluation of ofloxacin and dexamethasone based on the concept of pH triggered in situ gelation. Carbopol 934p was used as the gelling agent in combination with HPMC, as a viscosity-enhancing agent, benzalkonium chloride as preservative, sodium chloride as tonicity adjusting agent. The prepared formulations were liquid at the low pH and underwent rapid transition into viscous gel at the pH of the tear fluid. Formulations were evaluated for various rheological, in vitro and in vivo release characteristics. Infrared spectroscopy studies showed that there were no interactions between the drug and polymers. Viscosity of the prepared hydrogels lies in the optimum range and drug was released up to 85 % as the end of 13 h. The prepared in situ hydrogel was sterile, non-irritant to the eye. The present study indicated that it is possible to develop safe and physiologically effective in situ hydrogel which is patient compliant.
Downloads
References
Ameeduzzafar, Imam SS, Bukhari SN, Ali A. Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment. Artif Cells Nanomed Biotechnol. 2018;46(5):959-67.
Balasubramaniam J, Pandit JK. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. Drug Deliv. 2003;10(3):185-91.
Briedis DJ, Robson HG. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae. Antimicrob Agents Chemother. 1976;10(4):592-7.
Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61(3):377-92.
Drusano GL, Standiford HC, Plaisance K, Forrest A, Leslie J, Caldwell J. Absolute oral bioavailability of ciprofloxacin. Antimicrob Agents Chemother . 1986;30(3):444-6.
Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348-60.
Dubey A, Prabhu P. Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma. Int J Pharm Investig. 2014;4(3):112-8.
Hoare TR, Kohane DS. Hydrogels in drug delivery: Progress and challenges. Polymer. 2008;49(8):1993-2007.
Hsiue GH, Hsu SH, Yang CC, Lee SH, Yang IK. Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. Biomaterials. 2002;23(2):457-62.
Imam SS, Bukhari SN, Ahmad J, Ali A. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity. Int J Biol Macromol. 2018;108:650-9.
Kaur IP, Singh M, Kanwar M. Formulation and evaluation of ophthalmic preparations of acetazolamide. Int J Pharm. 2000;199(2):119-27.
Khan N, Aqil M, Ameeduzzafar, Imam SS, Ali A. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization. Pharm Dev Technol. 2015;20(6):662-9.
Mainardes RM, Urban MC, Cinto PO, Khalil NM, Chaud MV, Evangelista RC et al. Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets. 2005;6(3):363-71.
Makwana SB, Patel VA, Parmar SJ. Development and characterization of in situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results in pharma sciences. 2016;6:1-6.
Mandal S, Thimmasetty MK, Prabhushankar GL, Geetha MS. Formulation and evaluation of an in situ gel forming ophthalmic formulation of moxifloxacin hydrochloride. Int J Pharm Investig . 2012;2(2):78-82.
Mitan R, Jolly RG, Parikh, Megha B, Dharmesh MM. A pH triggered in situ gel forming ophthalmic drug delivery system for tropicamide. Drug Deliv Technol. 2007;5:44-9.
Nagam SP, Jyothi AN, Poojitha J, Aruna SA, Nadendla RR. A comprehensive review on hydrogels. Int J Curr Pharm Res. 2016;8(1):1-9.
Nelson JM, Chiller TM, Powers JH, Angulo FJ. Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin Infect Dis. 2007;44(7):977-80.
Panchasara A, Singh A, Mandavia D, Jha S, Tripathi C. Efficacy and safety of ofloxacin and its combination with dexamethasone in chronic suppurative otitis media. A randomised, double blind, parallel group, comparative study. Acta Otorhinolaryngol Ital. 2015;35(1):39-44.
Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS pharmscitech. 2003;4(4):480-8.
Shastri DH, Patel LD. A novel alternate to ocular drug delivery system: Hydrogel. Int J Pharm Res. 2010;2(1):1-13.
Shelley H, Rodriguez-Galarza RM, Duran SH, Abarca EM, Babu RJ. In situ gel formulation for enhanced ocular delivery of nepafenac. J Pharm Sci. 2018;107(12):3089-97.
Shoaib MH, Tazeen J, Merchant HA, Young RI. Evaluation of drug release kinetics from Ibuprofen matrix tablets using HPMC. Pak J Pharm Sci . 2006;19(2):119-24.
Singh V, Bushetti SS, Appala R, Shareef A, Imam SS, Singh M. Stimuli-sensitive hydrogels: A novel ophthalmic drug delivery system. Indian J Ophthalmol. 2010;58(6):477-81.
Song J, Bi H, Xie X, Guo J, Wang X, Liu D. Preparation and evaluation of sinomenine hydrochloride in situ gel for uveitis treatment. Int Immunopharmacol. 2013;17(1):99-107.
Soppimath KS, Aminabhavi TM, Dave AM, Kumbar SG, Rudzinski WE. Stimulus-responsive “smart” hydrogels as novel drug delivery systems. Drug Dev Ind Pharm. 2002;28(8):957-74.
Tsurufuji S, Kurihara AT, Ojima FU. Mechanisms of anti-inflammatory action of dexamethasone: blockade by hydrocortisone mesylate and actinomycin D of the inhibitory effect of dexamethasone on leukocyte infiltration in inflammatory sites. J Pharmacol Exp Ther. 1984;229(1):237-43.
Yadav S, Parvez N. A comparative evaluation of 0.3% eye drops and in situ forming gel of Pefloxacin mesylate in experimentally induced Pseudomonas conjunctivitis. Cont J Pharmacol Toxicol Res. 2008;2:1-5.
Zhidong L, Jiawei L, Shufang N, Hui L, Pingtian D, Weisan P. Study of an alginate/HPMC based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm . 2006;315(1):12-7.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
